REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: 978K Market Cap: 65.4B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: May 4, 2023 Before Market Opens
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast August 3, 2023 May 4, 2023 10.09 / 9.563.16B / 3BBeat! February 3, 2023 12.56 / 10.173.41B / 3.13BBeat! November 3, 2022 11.14 / 9.822.94B / 2.94BAugust 3, 2022 9.77 / 8.622.86B / 2.79BBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 2, 2023 798.45 806.72 815.24
797.02
610K -1.03% May 1, 2023 806.72 803.71 811.55
802.12
297K 0.61% Apr 28, 2023 801.79 788.99 806.08
788
470K 1.20% Apr 27, 2023 792.29 775.33 796.42
774.06
749K 1.84% Apr 26, 2023 778 781.77 784.77
771.14
585K -1.47% Apr 25, 2023 789.58 797.27 801.82
784.84
467K -0.94% Apr 24, 2023 797.04 800.43 806.19
795.13
375K -0.46% Apr 21, 2023 800.73 798.42 804.72
797.26
545K 0.33% Apr 20, 2023 798.1 805.42 805.62
796.23
495K -1.33% Apr 19, 2023 808.86 804.73 810.17
803.52
353K 0.11% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug finance.yahoo.com Mar 29, 2023 1:28 pm UPDATE 3-U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents finance.yahoo.com Mar 29, 2023 10:35 am
Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases finance.yahoo.com Mar 29, 2023 7:30 am
Technical Assessment: Bearish in the Intermediate-Term finance.yahoo.com Mar 29, 2023 7:00 am
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease finance.yahoo.com Mar 28, 2023 9:30 pm
Drug, Chip Stocks Hit 52-Week Highs As One Breaks Out Of Bullish Chart Pattern finance.yahoo.com Mar 28, 2023 4:20 pm
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars finance.yahoo.com Mar 28, 2023 4:02 pm
Unity (UNX) Down on Disappointing Results From Wet AMD Study finance.yahoo.com Mar 28, 2023 3:25 pm
The 7 Best Biotech Stocks to Buy for February 2023 finance.yahoo.com Mar 28, 2023 1:51 pm
Compared to Estimates, Regeneron (REGN) Q4 Earnings: A Look at Key Metrics finance.yahoo.com Mar 28, 2023 12:45 pm
Regeneron poised to benefit from bounce-back of eye drug finance.yahoo.com Mar 28, 2023 12:20 pm
Wall Street Has High Hopes for These 2 Nasdaq Stocks finance.yahoo.com Mar 28, 2023 12:02 pm
Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update finance.yahoo.com Mar 28, 2023 12:00 pm
Merck's drug boosts exercise capacity in pulmonary hypertension patients finance.yahoo.com Mar 28, 2023 12:00 pm
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover finance.yahoo.com Mar 28, 2023 11:15 am
Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme finance.yahoo.com Mar 28, 2023 10:50 am
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript (Corrected) finance.yahoo.com Mar 28, 2023 9:47 am
Analyst Report: Regeneron Pharmaceuticals, Inc. finance.yahoo.com Mar 28, 2023 9:21 am
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today finance.yahoo.com Mar 28, 2023 9:20 am
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL finance.yahoo.com Mar 28, 2023 9:04 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!